This article is an orphan, as no other articles link to it . Please introduce links to this page from related articles ; try the Find link tool for suggestions. (October 2024) |
Fiona M. Walter | |
---|---|
Nationality | British |
Alma mater | University of Cambridge |
Scientific career | |
Institutions | University of Cambridge Queen Mary University of London |
Thesis | Family history of common chronic disease in primary care : the patient's perspective (2007) |
Fiona Mary Walter is a British physician, professor and the director of the Wolfson Institute of Population Health at Queen Mary University of London. Her research considers the development of new diagnostics for the early detection and prevention of cancer.
Walter studied medicine at the University of Cambridge, earning her Bachelor of Medicine, Bachelor of Surgery in 1983. [1] She worked as a general practitioner in Cambridge, and completed a doctorate on chronic disease in primary care. [2]
Walter was a Reader in Cancer Research at the University of Cambridge. Here she led Cancer Research UK's CanTest, a programme that looked to improve early detection of upper gastrointestinal cancer, and was involved with the National Institute for Health and Care Research Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis. [3] At Cambridge Walter worked in primary care oncology on the patient pathway. [4]
Walter joined Queen Mary University of London in 2021. [5] Here she was made Director of the Wolfson Institute of Population Health and co-lead of the Cancer Detection and Diagnosis Unit.
In 2023 she developed a ten-point plan that focussed on improve cancer services in the United Kingdom. [6] She launched a new Centre for Cancer Screening, Prevention and Early Diagnosis at Queen Mary University of London in 2024. [7]
She holds honorary positions at the University of Melbourne, in South Africa and in Zimbabwe. [8]
Barts and The London School of Medicine and Dentistry, commonly known as Barts or BL, is a medical and dental school in London, England. The school is part of Queen Mary University of London, a constituent college of the federal University of London, and the United Hospitals. It was formed in 1995 by the merger of the London Hospital Medical College and the Medical College of St Bartholomew's Hospital.
The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.
The Cambridge Biomedical Campus is the largest centre of medical research and health science in Europe. The site is located at the southern end of Hills Road in Cambridge, England.
Frances Rosemary Balkwill is an English scientist, Professor of Cancer Biology at Queen Mary University of London, and author of children's books about scientific topics.
The objective of cancer screening is to detect cancer before symptoms appear, involving various methods such as blood tests, urine tests, DNA tests, and medical imaging. The purpose of screening is early cancer detection, to make the cancer easier to treat and extending life expectancy. In 2019, cancer was the second leading cause of death globally; more recent data is pending due to the COVID-19 pandemic.
Thomas M. Kolb is an American radiologist specializing in the detection and diagnosis of breast cancer in young, predominantly high-risk premenopausal women. He has served as an assistant clinical professor of Radiology at Columbia University College of Physicians and Surgeons from 1994–2010. Kolb is double board certified, having received his training in pediatrics at the Albert Einstein College of Medicine in Bronx, New York, and in diagnostic radiology at the Columbia-Presbyterian Medical Center in New York.
Jane Wardle FBA FMedSci was a professor of clinical psychology and director of the Cancer Research UK Health Behaviour Research Centre at University College London. She was one of the pioneers of health psychology in the UK and internationally, known for her seminal work on the contribution of psychology to public health, particularly the role of psychological research in cancer prevention and work on the behavioural and genetic determinants of eating behaviour and obesity.
Patricia Mary Greenhalgh is a British professor of primary health care at the University of Oxford, and retired general practitioner.
The History of Modern Biomedicine Research Group (HoMBRG) is an academic organisation specialising in recording and publishing the oral history of twentieth and twenty-first century biomedicine. It was established in 1990 as the Wellcome Trust's History of Twentieth Century Medicine Group, and reconstituted in October 2010 as part of the School of History at Queen Mary University of London.
Jack Martin Cuzick is an American-born British academic, director of the Wolfson Institute of Preventive Medicine in London and head of the Centre for Cancer Prevention. He is the John Snow Professor of Epidemiology at the Wolfson Institute, Queen Mary University of London.
Fiona Jane Gilbert is a Scottish radiologist and academic.
Amanda Herbert is a British cytopathologist and histopathologist.
Rebecca Clare Fitzgerald is a British medical researcher who studies cancer evolution to find new ways to detect and prevent cancer, with a particular focus on oesophageal cancer. She is a tenured Professor of Cancer Prevention and is the founding Director at the Early Cancer Institute of the University of Cambridge.
Zion Tse is a professor in robotics, and the director of Centre for Bioengineering at the School of Engineering and Materials Science, Queen Mary, University of London.
Lisa C. Richardson is an American physician who is the Director of CDC Division of Cancer Prevention and Control. She is responsible for the Colorectal Cancer Control Program, the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries.
Paul Coulthard, BDS, MFGDP(UK), MDS, FDSRCS(Eng), FDSRCS(OS), PhD, FDSRCPS(Glas), FFDTRCS(Ed), FDSRCS(Ed), FCGDent is a British Academic, Surgeon and Scientist.
Dame Lyn Susan Chitty is a British physician and Professor of Genetics and Fetal Medicine at University College London. She is the deputy director of the National Institute for Health and Care Research Great Ormond Street Hospital Biomedical Research Centre. She is the 2022 president of the International Society for Prenatal Diagnosis. Her research considers non-invasive prenatal diagnostics. She was made a Dame in the 2022 New Year Honours.
Irene Ghobrial is an American-Egyptian physician who is a professor at the Dana–Farber Cancer Institute and Harvard Medical School, where her research investigates early detection, mechanisms of disease progression and early interception of multiple myeloma. She is interested in why certain patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) develop multiple myeloma.
Jacqueline Dianne Kidd (Ngāpuhi) is a Māori academic, and is a full professor at the Auckland University of Technology, specialising in Māori health and anti-racism in health practices and processes.
Jane Eddleston is a British medical doctor, professor and critical care consultant at Manchester Royal Infirmary. In 2022 she became the first woman doctor to win the Faculty of Intensive Care Medicine Gold Medal.